IAP BIR domain binding compounds
US8648094B2 · kind B2 · utility
0Cited by
8References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2012 |
| Grant date | Feb 11, 2014 |
| Priority date | — |
| Expiry date | Mar 30, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/02
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Disclosed herein is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I:or a prodrug, or a pharmaceutically acceptable salt, or labeled with a detectable label or an affinity tag thereof; wherein R1, R1a, R100, R100a, R2, R200, W, B, and W1 are defined herein. Also disclosed are methods of using compounds of Formula I to treat proliferative disorders such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.